1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Desmoid Fibromatosis: new trials by email Literature Review of Desmoid Fibromatosis trials Research Report on Desmoid Fibromatosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment - Desmoid Fibromatosis | Phase 3 | Completed | National Cancer Institute (NCI) | 87 | 2014-03-21 | 2026-06-24 |
Desmoid Tumors (1)
Fibroma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Fibrous Tissue (1)
Sorafenib (1)
National Cancer Institute (NCI) (1)
Canada (1) · United States (1)
Mrinal M Gounder (1)
PMID 30575484, PMID 33258687, PMID 34420143
U10CA031946 (1), U10CA180821 (1)